GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Accounts Payable

Radiopharm Theranostics (ASX:RAD) Accounts Payable : A$9.02 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Accounts Payable?

Radiopharm Theranostics's Accounts Payable for the quarter that ended in Dec. 2023 was A$9.02 Mil.

Radiopharm Theranostics's quarterly Accounts Payable increased from Dec. 2022 (A$1.92 Mil) to Jun. 2023 (A$2.96 Mil) and increased from Jun. 2023 (A$2.96 Mil) to Dec. 2023 (A$9.02 Mil).

Radiopharm Theranostics's annual Accounts Payable increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$1.19 Mil) and increased from Jun. 2022 (A$1.19 Mil) to Jun. 2023 (A$2.96 Mil).


Radiopharm Theranostics Accounts Payable Historical Data

The historical data trend for Radiopharm Theranostics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Accounts Payable Chart

Radiopharm Theranostics Annual Data
Trend Jun22 Jun23
Accounts Payable
1.19 2.96

Radiopharm Theranostics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Payable 0.35 1.19 1.92 2.96 9.02

Radiopharm Theranostics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Radiopharm Theranostics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Radiopharm Theranostics (ASX:RAD) Business Description

Traded in Other Exchanges
Address
62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines